Common Stock, par value $0.0001 per share
- Symbol
- TVGN
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01, 9.01 · 8-K
Tevogen Inc.
TVGNNASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events. On September 29, 2026, Tevogen Inc. (the “Company”) received written notice from The Nasdaq Stock Market LLC notifying the Company that it had regained compliance with the $50 million minimum market value of the listed securities requirement under Nasdaq Listing Rule 5450(b)(2)(A) for continued listing on The Nasdaq Global Market. Accordingly, the matter is now closed.…
Press release in this filing
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements →Company context
Current securities
Recent company filings
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 16, 2026
- 4 filingSep 15, 2026
- Other EventsSep 10, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Submission of Matters to a Vote of Security HoldersAug 26, 2026
- S-8 filingAug 24, 2026
Registered securities in this filing
Tevogen Inc. · 8-K · Filed 2026-09-30
Warrants, exercisable for $575.00 per share
- Symbol
- TVGNW
- Exchange
- NASDAQ
- Classification
- WARRANT
- Status
- Current
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item
8.01 Other Events.
On
September 29, 2026, Tevogen Inc. (the “Company”) received written notice from The Nasdaq Stock Market LLC notifying the Company
that it had regained compliance with the $50 million minimum market value of the listed securities requirement under Nasdaq Listing Rule
5450(b)(2)(A) for continued listing on The Nasdaq Global Market. Accordingly, the matter is now closed.
On
September 30, 2026, the Company issued a press release announcing that it regained compliance with the requirement. A copy of this press
release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Filed exhibits (1)
Exhibit 99.1 Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements Both previously disclosed Nasdaq compliance matters are now closed September 30, 2026 WARREN, N.J., Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN ), an integrated healthcare enterprise combining biotechnology, artificial intelligence, and healthcare services to improve the affordability and accessibility of life-saving medicines, today announced that it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) on September 29, 2026, confirming that the Company had regained compliance with the $50 million minimum market value of listed securities requirement under Nasdaq Listing Rule 5450(B)(2)(A) for continued listing on The Nasdaq Global Market. As previously announced, on September 9, 2026, the Company had received written notice from Nasdaq confirming that it had regained compliance with the minimum market value of publicly held shares requirement under Nasdaq Listing Rules 5450(B)(2)(C) and 5450(B)(3)(C). With both requirements satisfied, the related Nasdaq compliance matters are now closed. About Tevogen Tevogen is a healthcare enterprise focused on …
Open exhibit ↗